Work

Transitioning from development to commercial: risk-based guidance for critical materials management in cell therapies

Year: 2020

Type: article

Source: Cytotherapy

DOI: 10.1016/j.jcyt.2020.06.011

Authors: Michael Scott, Dominic Clarke, Yonatan Lipsitz, Harvey Brandwein, Julie Allickson, Dalia Alzebdeh, Sasha Aleksic, Crystal Kraft, Lexan Lhu, Kenneth Cornetta

Institutions: International Society for Cellular Therapy, Sana Biotechnology (United States), Cook MyoSite, Inc. (United States), Wake Forest University Health Sciences, Wake Forest University, West Pharmaceutical Services (United States), Indiana University School of Medicine

Language: English

Topic: Biomedical Ethics and Regulation

Subfield: Physiology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3045442701

FWCI: 0.146

Cites: 15

Cited by: 4

Related to: 10